Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Novel GK activators claimed by Roche as antidiabetic agents

Dec. 9, 2009

Takeda discloses novel ACC inhibitors for the treatment of obesity

Dec. 9, 2009

CORE trial data suggest efficacy of deferasirox in hereditary hemochromatosis

Dec. 9, 2009

Forest identifies novel SCD1 inhibitors for the treatment of obesity

Dec. 7, 2009

FDA approves Novo Nordisk's Vagifem 10 mcg for atrophic vaginitis due to menopause

Dec. 7, 2009

Endo provides regulatory update on Aveed for men with low testosterone

Dec. 4, 2009

Agreement reached on U.S. approval pathway for Pompe disease treatment

Dec. 4, 2009

Bayer Schering Pharma claims novel series of adenosine A1 agonists

Dec. 4, 2009

Roche reports encouraging results from phase III trials of taspoglutide in diabetes

Dec. 4, 2009

FIELD trial data support beneficial effects of fenofibrate in type 2 diabetes patients

Dec. 4, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...